Article
Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer’s models
2026-01-21
Abstract excerpt
Alzheimer’s disease (AD) remains without effective disease-modifying therapies, underscoring the need for interventions that target interconnected molecular and cellular processes driving cognitive decline. Leveraging a cross-species translational framework integrating a progressive rat model of Alzheimer’s disease with human iPSC-derived neurons carrying familial AD mutations, we identify agomelatine (AGO) as a d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9d811cbf-ca7c-5d5e-849f-dced6a476996
- DOI
- 10.64898/2026.01.17.700104
